Cancer Biomarkers & Screening

A malignancy biomarker alludes to a substance or procedure that is characteristic of the nearness of disease in the body. A biomarker might be an atom emitted by a tumor or a particular reaction of the body to the nearness of malignant growth. Hereditary, epigenetic, proteomic, glycomic, and imaging biomarkers can be utilized for malignancy finding, guess, and the study of disease transmission. In a perfect world, such biomarkers can be tested in non-intrusively gathered biofluids like blood or serum

    Related Conference of Cancer Biomarkers & Screening

    February 05-06, 2026

    11th World Conference on Breast and Cervical Cancer

    Paris, France
    February 19-20, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    February 19-20, 2026

    8th International Conference on Women Oncology

    Miami, USA
    March 09-10, 2026

    4th World Congress on Oral Cancer

    Singapore City, Singapore
    March 30-31, 2026

    26th World Congress on Cancer and Diagnostics

    London, UK
    June 15-16, 2026

    10th Global Meeting on Oncology and Radiology

    Paris, France
    June 22-23, 2026

    16th World Congress on Breast Cancer

    Dubai, UAE
    June 23-24, 2026

    27th World Congress on Cancer Summit

    Paris, France
    July 27-28, 2026

    6th World Congress on Breast Cancer

    Rome, Italy
    September 28-29, 2026

    36th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    September 29-30, 2026

    5th Experts Meeting on Cancer Medicine, Radiology & Treatment

    Aix-en-Provence, France

    Cancer Biomarkers & Screening Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in